Petra Reinke

Petra Reinke's AcademicInfluence.com Rankings

Petra Reinke

Physics

#7571

World Rank

#9613

Historical Rank

physics Degrees

Download Badge

Physics

Petra Reinke's Degrees

PhD Physics Stanford University
Masters Physics University of California, Berkeley
Bachelors Physics University of California, Berkeley

Why Is Petra Reinke Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Petra Reinke's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. (2009) (498)
Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection (2004) (405)
Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells (2005) (363)
Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts (2009) (343)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial (2011) (334)
Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited (1999) (326)
T-cell epitope mapping by flow cytometry (1998) (315)
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. (2012) (306)
Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. (2002) (297)
Analysis of CD8 T cell reactivity to cytomegalovirus using protein‐spanning pools of overlapping pentadecapeptides (2000) (282)
Monocyte deactivation-rationale for a new therapeutic strategy in sepsis (1996) (279)
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). (2006) (257)
Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD) (2005) (254)
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population (2018) (248)
Clinical aspects: from systemic inflammation to 'immunoparalysis'. (2000) (245)
Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. (2005) (237)
Terminally Differentiated CD8+ T Cells Negatively Affect Bone Regeneration in Humans (2013) (236)
CYTOMEGALOVIRUS INFECTION IN TRANSPLANT RECIPIENTS THE ROLE OF TUMOR NECROSIS FACTOR (1994) (236)
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. (2019) (222)
Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. (2009) (212)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (2020) (194)
Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1 (2002) (192)
Distribution of human CMV‐specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms (1999) (174)
Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. (1997) (170)
Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. (2005) (163)
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome (2016) (152)
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. (2002) (151)
A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. (2000) (148)
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial. (2017) (144)
Enzyme-Linked Immunosorbent Spot Assay for Donor-Reactive Interferon-Gamma-Producing Cells Identifies T-Cell Presensitization and Correlates with Graft Function at 6 and 12 Months in Renal-Transplant Recipients (2004) (143)
Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients (1999) (142)
Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. (2006) (136)
BK Virus‐Specific Immunity Kinetics: A Predictor of Recovery From Polyomavirus BK‐Associated Nephropathy (2011) (131)
Old‐for‐Old Kidney Allocation Allows Successful Expansion of the Donor and Recipient Pool (2003) (127)
TCR Repertoire Analysis by Next Generation Sequencing Allows Complex Differential Diagnosis of T Cell–Related Pathology (2013) (122)
Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. (2008) (116)
Five‐Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study (2015) (114)
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy (2020) (110)
Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. (1999) (107)
ENHANCED GRANULYSIN mRNA EXPRESSION IN URINARY SEDIMENT IN EARLY AND DELAYED ACUTE RENAL ALLOGRAFT REJECTION (2004) (107)
RAPID DECLINE OF ANTIBODIES AFTER HEPATITIS A IMMUNIZATION IN LIVER AND RENAL TRANSPLANT RECIPIENTS (2001) (106)
Overcoming Challenges Facing Advanced Therapies in the EU Market. (2016) (106)
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. (1996) (106)
Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners (2015) (102)
IL‐15 dependent induction of IL‐18 secretion as a feedback mechanism controlling human MAIT‐cell effector functions (2015) (101)
Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial (2010) (100)
BK polyomavirus infection and nephropathy: the virus–immune system interplay (2011) (100)
Donor–Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor‐Specific HLA Antibodies Following Renal Transplantation (2017) (100)
Sustained BK Viruria as an Early Marker for the Development of BKV-Associated Nephropathy: Analysis of 4128 Urine and Serum Samples (2009) (94)
Late-acute renal allograft rejection and symptomless cytomegalovirus infection (1995) (93)
Analysis of Tumor Necrosis Factor‐α, Transforming Growth Factor‐β, Interleukin‐10, IL‐6, and Interferon‐γ Gene Polymorphisms in Patients With Chronic Periodontitis (2006) (92)
Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3‐Year Results From the Randomized ZEUS Study (2012) (90)
Adoptive T‐Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy (2009) (89)
Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies. (2007) (88)
Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. (2008) (87)
Cross‐Validation of IFN‐γ Elispot Assay for Measuring Alloreactive Memory/Effector T Cell Responses in Renal Transplant Recipients (2013) (86)
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts (2003) (85)
Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. (1994) (83)
Salvage Chemotherapy for Refractory and Relapsed Posttransplant Lymphoproliferative Disorders (PTLD) After Treatment With Single-Agent Rituximab (2007) (77)
A NOVEL SELECTIVE EXTRACORPOREAL INTERVENTION IN SEPSIS: IMMUNOADSORPTION OF ENDOTOXIN, INTERLEUKIN 6, AND COMPLEMENT-ACTIVATING PRODUCT 5a (2007) (76)
Absolute and functional iron deficiency in professional athletes during training and recovery. (2012) (76)
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial (2020) (75)
The Loss of BKV‐specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication (2015) (74)
High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. (2009) (73)
Routine immunizations in adult renal transplant recipients. (1997) (73)
Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome (2014) (73)
The enigma of CD57+CD28– T cell expansion—anergy or activation? (1996) (69)
Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion (2010) (69)
HLA Type‐Independent Method to Monitor Polyoma BK Virus‐Specific CD4+ and CD8+ T‐Cell Immunity (2006) (69)
Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end‐stage liver disease (1996) (68)
Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. (2006) (68)
B-Cell-Related Biomarkers of Tolerance are Up-Regulated in Rejection-Free Kidney Transplant Recipients (2013) (67)
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME (2018) (67)
Symptomatic lymphoceles after kidney transplantation – multivariate analysis of risk factors and outcome after laparoscopic fenestration (2010) (65)
Diagnosis and treatment of post‐transplantation lymphoproliferative disorder in pediatric heart transplant patients (2009) (65)
Novel GMP‐Compatible Protocol Employing an Allogeneic B Cell Bank for Clonal Expansion of Allospecific Natural Regulatory T Cells (2014) (64)
KIR/HLA Ligand Incompatibility in Kidney Transplantation (2007) (63)
Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation. (2013) (63)
Sepsis: time has come to focus on the later stages. (2008) (60)
In vivo effect of bone marrow‐derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia (2011) (60)
BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study (2018) (59)
Heightened Expression of the Cytotoxicity Receptor NKG2D Correlates with Acute and Chronic Nephropathy After Kidney Transplantation (2007) (59)
Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs. (2013) (58)
Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo? (2015) (58)
Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases (2011) (56)
Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells (2000) (55)
Improvement of Monocyte Function — A New Therapeutic Approach? (1994) (54)
BK-VP3 as a New Target of Cellular Immunity in BK Virus Infection (2011) (54)
Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients. (2014) (52)
Immunological monitoring of the inflammatory process: Which variables? When to assess? (1999) (51)
LATE ACUTE REJECTION IN LONG‐TERM RENAL ALLOGRAFT RECIPIENTS (1994) (50)
Evidence for Genetic Susceptibility Towards Development of Posttransplant Lymphoproliferative Disorder in Solid Organ Recipients (2007) (50)
Current characteristics and outcome of cytomegalovirus infections after kidney transplantation (2014) (49)
Excessive Tryptophan Catabolism Along the Kynurenine Pathway Precedes Ongoing Sepsis in Critically Ill Patients (2010) (49)
Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional Properties (2019) (49)
Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. (2008) (49)
The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients. (2013) (49)
Novel Approach for Improved Assessment of Phenotypic and Functional Characteristics of BKV-Specific T-Cell Immunity (2011) (49)
Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients. (1996) (48)
Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy. (2020) (48)
Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. (2006) (48)
Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression (2009) (48)
International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial (2015) (46)
Human Cytomegalovirus Reactivation in Bone-Marrow-Derived Granulocyte/Monocyte Progenitor Cells and Mature Monocytes (2000) (46)
Epstein–Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course (2006) (46)
The Influence of Recovery and Training Phases on Body Composition, Peripheral Vascular Function and Immune System of Professional Soccer Players (2009) (45)
Immunomodulatory placental‐expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty (2018) (45)
Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial (2017) (45)
Cytomegalovirus‐Specific Regulatory and Effector T Cells Share TCR Clonality—Possible Relation to Repetitive CMV Infections (2012) (44)
Analysis of tumor necrosis factor-alpha, transforming growth factor-beta, interleukin-10, IL-6, and interferon-gamma gene polymorphisms in patients with chronic periodontitis. (2006) (44)
Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft. (2001) (43)
Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation (2015) (43)
Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab. (2007) (42)
Treatment with granulocyte–macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock (2010) (42)
Development of Kaposi's sarcoma under sirolimus‐based immunosuppression and successful treatment with imiquimod (2008) (42)
Diagnostic value of an immune monitoring program for the clinical management of immunosuppressed patients with septic complications (1989) (41)
Consider delayed immunosuppression into the concept of sepsis. (2008) (41)
CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor (2017) (41)
Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: a single center experience. (2004) (39)
Putting a price tag on novel autologous cellular therapies. (2016) (38)
Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. (2006) (38)
Expansion of Memory-Type CD8+ T Cells Correlates With the Failure of Early Immunosuppression Withdrawal After Cadaver Liver Transplantation Using High-Dose ATG Induction and Rapamycin (2013) (38)
Exercise capacity and body composition in living-donor renal transplant recipients over time. (2009) (37)
Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection (2007) (37)
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells (2017) (37)
HLA type‐independent generation of antigen‐specific T cells for adoptive immunotherapy (2005) (37)
Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients. (2001) (37)
Comparative characterization of decellularized renal scaffolds for tissue engineering (2017) (36)
Potent Early Immune Response After Kidney Transplantation in Patients of the European Senior Transplant Program (2009) (36)
Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study. (2015) (35)
Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro. (1997) (35)
Permanent CNI Treatment for Prevention of Renal Allograft Rejection in Sensitized Hosts Can Be Replaced by Regulatory T Cells (2012) (35)
Immunomodulation by adoptive regulatory T‐cell transfer improves Coxsackievirus B3‐induced myocarditis (2018) (35)
Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients. (2004) (35)
Measurement of Anti-Human Cytomegalovirus T Cell Reactivity in Transplant Recipients and Its Potential Clinical Use: A Mini-Review (2000) (33)
Peripheral Blood–Derived Virus-Specific Memory Stem T Cells Mature to Functional Effector Memory Subsets with Self-Renewal Potency (2015) (33)
Inflammatory activation and recovering BKV‐specific immunity correlate with self‐limited BKV replication after renal transplantation (2014) (33)
Monitoring tolerance and rejection in organ transplant recipients (2011) (32)
Impaired Insulin Sensitivity as an Underlying Mechanism Linking Hepatitis C and Posttransplant Diabetes Mellitus in Kidney Recipients (2009) (32)
Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study. (2019) (32)
Different risk factor profiles distinguish early‐onset from late‐onset BKV‐replication (2015) (32)
Can We Use Biomarkers and Functional Assays to Implement Personalized Therapies in Transplantation? (2009) (32)
Human CD45RA− FoxP3hi Memory‐Type Regulatory T Cells Show Distinct TCR Repertoires With Conventional T Cells and Play an Important Role in Controlling Early Immune Activation (2015) (31)
Predicting the outcome of renal transplantation (2012) (31)
Burkitt post‐transplantation lymphoma in adult solid organ transplant recipients (2012) (31)
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial (2017) (31)
Anti-CD4 therapy of acute rejection in long-term renal allograft recipients (1991) (30)
blind randomized placebo-controlled multicenter trial (2009) (30)
IL‐6 and IL‐10 in post‐transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T‐cell subsets in 38 patients undergoing treatment (2011) (30)
The role of CD4+ T cells in BKV-specific T cell immunity (2014) (30)
Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants. (2004) (29)
Prophylaxis of recurrent urinary tract infection after renal transplantation by cranberry juice and L-methionine. (2012) (29)
Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts1 (2003) (29)
Diagnostic and predictive value of an immune monitoring program for complications after kidney transplantation. (1992) (28)
Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurements. (2008) (28)
The business case for cell and gene therapies (2014) (27)
The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains (2019) (27)
Human peripheral blood and bone marrow Epstein–Barr virus‐specific T‐cell repertoire in latent infection reveals distinct memory T‐cell subsets (2010) (27)
Molecular phenotypes of acute rejection predict kidney graft prognosis. (2010) (27)
VEGF - Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC. (2019) (26)
Diagnostic value of T-cell monitoring assays in kidney transplantation (2009) (26)
Peripheral T cell activation in long-term renal transplant patients: concordant upregulation of adhesion molecules and cytokine gene transcription. (1996) (26)
Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients (2012) (26)
Expansion of a CD 3+4-8- TCR alpha/beta- T lymphocyte population in renal allograft recipients. (1989) (25)
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. (2015) (25)
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry (2017) (25)
ABO desensitization affects cellular immunity and infection control after renal transplantation (2015) (24)
Rat Cytomegalovirus Infection Interferes with Anti‐CD4 mAb‐(RIB 5/2) Mediated Tolerance and Induces Chronic Allograft Damage (2006) (24)
Long‐term outcome of ATG vs. Basiliximab induction (2011) (24)
Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes. (2009) (24)
Discordant Expression of LFA-1 VLA-4α, VLA-β1, CD45RO and CD28 on T-Cell Subsets: Evidence for Multiple Subsets of ‘Memory’ T Cells (1994) (23)
Whole blood flow cytometric measurement of NFATc1 and IL‐2 expression to analyze cyclosporine A‐mediated effects in T cells (2010) (23)
Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series (2019) (23)
A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV. (2014) (23)
Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer. (2011) (23)
Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects (2019) (23)
Accelerating Patients’ Access to Advanced Therapies in the EU (2017) (22)
Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells (2018) (22)
Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells (2021) (22)
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allografts. (2001) (22)
Preferential Expansion of Human Virus-Specific Multifunctional Central Memory T Cells by Partial Targeting of the IL-2 Receptor Signaling Pathway: The Key Role of CD4+ T Cells (2012) (21)
Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype (2021) (21)
CD31+ Naïve Th Cells Are Stable during Six Months Following Kidney Transplantation: Implications for Post‐transplant Thymic Function (2005) (21)
Estimated nephron number of the remaining donor kidney: impact on living kidney donor outcomes. (2016) (21)
Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients. (2013) (21)
Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors (2017) (20)
Human Cytomegalovirus Infection in Transplant Recipients: Role of TNF-α for Reactivation and Replication of Human Cytomegalovirus (1998) (20)
Comparing Humoral and Cellular Immune Response Against HBV Vaccine in Kidney Transplant Patients (2015) (20)
ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results. (2003) (20)
T cell response to the cytomegalovirus major capsid protein (UL86) is dominated by helper cells with a large polyfunctional component and diverse epitope recognition. (2008) (20)
Colour-coded duplex sonography in the diagnostic assessment of vascular complications after kidney transplantation in children (1997) (20)
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer (2021) (20)
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients (2020) (20)
Generation of HCMV-specific T-cell Lines From Seropositive Solid-organ-transplant Recipients for Adoptive T-cell Therapy (2009) (20)
Evaluation of adherence and tolerability of prolonged‐release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study (2018) (19)
Pretransplant prophylactic rituximab to prevent Epstein‐Barr virus (EBV) viremia in EBV‐seronegative kidney transplant recipients from EBV‐seropositive donors: results of a pilot study (2016) (19)
Adult Tissue Extracellular Matrix Determines Tissue Specification of Human iPSC‐Derived Embryonic Stage Mesodermal Precursor Cells (2020) (19)
Immune response after adenoviral gene transfer in syngeneic heart transplants: effects of anti-CD4 monoclonal antibody therapy. (2000) (19)
Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients (2014) (19)
Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial. (2009) (19)
Industry–academia collaborations for biomarkers (2015) (19)
Generation of integration free induced pluripotent stem cells from fibrodysplasia ossificans progressiva (FOP) patients from urine samples. (2016) (19)
Prevalence and Clinical Correlates of Chronic Hepatitis E Infection in German Renal Transplant Recipients With Elevated Liver Enzymes (2018) (19)
Kidney transplant monitoring by urinary flow cytometry: Biomarker combination of T cells, renal tubular epithelial cells, and podocalyxin-positive cells detects rejection (2020) (18)
Generation of EBV-specific T Cells for Adoptive Immunotherapy: A Novel Protocol Using Formalin-fixed Stimulator Cells to Increase Biosafety (2007) (18)
Abnormalities of pulmonary diffusion capacity in long-term survivors after kidney transplantation. (2002) (18)
Clindamycin–primaquine for pneumocystis jiroveci pneumonia in renal transplant patients (2014) (17)
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial (2021) (17)
Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium. (2011) (17)
Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy. (2018) (17)
Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation (2019) (17)
Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial (2015) (17)
Clinical Development of Cell Therapies: Setting the Stage for Academic Success (2017) (16)
Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications (2021) (16)
Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic survey (2009) (16)
Pretransplant immune risk assessment (2009) (16)
BCR‐ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients (2010) (15)
Living kidney donation: anemia and inflammation in the early postoperative period. (2006) (14)
Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation. (1996) (14)
Lymphocyte markers and prediction of long-term renal allograft acceptance (2009) (14)
Human Bone Marrow as a Source to Generate CMV-specific CD4+ T Cells With Multifunctional Capacity (2009) (14)
Malignant tumours after renal transplantation. (1996) (14)
HCMV-specific T-cell Therapy: Do Not Forget Supply of Help (2013) (14)
WCN 2003 satellite symposium on kidney transplantation in the elderly, Weimar, Germany, June 12-14, 2003. (2004) (14)
Parallel generation of easily selectable multiple nephronal cell types from human pluripotent stem cells (2018) (14)
Induction of pre‐transplant Epstein–Barr virus (EBV) infection by donor blood transfusion in EBV–seronegative recipients may reduce risk of post‐transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases (2005) (13)
Percutaneous Computer Tomography-Guided Ethanol Sympathicolysis for the Treatment of Resistant Arterial Hypertension (2014) (13)
Short-Term Anti-CD4 Plus Anti-TNF-&agr; Receptor Treatment in Allogeneic Small Bowel Transplantation Results in Long-Term Survival (2007) (13)
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials (2018) (13)
Decrease of the Proportion of HLA-DR + Monocytes as Prognostic Parameter for the Clinical Outcome of Septic Disease (1990) (13)
Intragraft overexpression of interleukin-4 is neither sufficient nor essential for tolerance induction to cardiac allografts in a high-responder strain combination. (1999) (13)
Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy. (2016) (13)
The concept of the "perisinusoidal functional unit" of the liver--importance to pathological processes. (1987) (13)
BKV clearance time correlates with exhaustion state and T-cell receptor repertoire shape of BKV-specific T-cells in renal transplant patients (2019) (12)
RENAL FUNCTION, EFFICACY AND SAFETY OF EVEROLIMUS (RAD) / ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) THERAPY AFTER CALCINEURIN INHIBITOR (CNI) WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: FINAL OUTCOMES OF THE ZEUS STUDY: 264 (2008) (12)
State of the art on the research for biomarkers allowing individual, tailor-made minimization of immunosuppression (2010) (12)
Association between CMV-related graft injury and circulating cytokine-producing CD8+ memory cells. (1995) (12)
Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation (2017) (12)
CD3+ CD57+ lymphocytes are not likely to be involved in antigen‐specific rejection processes in long‐term allograft recipients (1992) (12)
T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy. (2016) (11)
Five‐year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low‐exposure cyclosporine versus standard therapy (2018) (11)
Autoimmunity and transplantation: a meeting at the crossroads in Berlin (2008) (11)
Effects of Treatment of Asymptomatic Hyperuricemia on Graft Survival and Mortality in Kidney Transplant Recipients. (2016) (11)
Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach (2018) (11)
[Cytokine determination. Diagnostic significance from the clinical and immunological viewpoint]. (1997) (11)
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019 (2020) (11)
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells (2022) (11)
Intravenous Iloprost treatment for severe bone pain caused by sickle cell crisis (2004) (11)
Virus‐specific T‐cell therapy in solid organ transplantation (2016) (11)
Two decades of the Eurotransplant Senior Program: the gender gap in mortality impacts patient survival after kidney transplantation (2019) (10)
The Identity Card of T cells - Clinical utility of T cell receptor (TCR ) repertoire analysis in transplantation. (2019) (10)
TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats. (2006) (10)
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials (2018) (10)
Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process. (1995) (10)
Accurate prediction of kidney allograft outcome based on creatinine course in the first 6 months posttransplant. (2005) (10)
Intensive blood pressure control is associated with improved patient and graft survival after renal transplantation (2019) (10)
Transplantectomy is associated with presensitization with donor-reactive T cells and graft failure after kidney retransplantation: a cohort study (2018) (10)
Adoptive transfer of ex vivo expanded regulatory T-cells improves immune cell engraftment and therapy-refractory chronic GvHD. (2022) (9)
Selective in vivo deletion of alloactivated TH1 cells by OKT3 monoclonal antibody in acute rejection. (1997) (9)
An immune monitoring program for controlling immunosuppressive therapy. (1989) (9)
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients (2019) (9)
Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1. (2001) (9)
Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial (2017) (9)
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial. (2016) (9)
Efficacy and safety of conversion from cyclosporine to everolimus in living‐donor kidney transplant recipients: an analysis from the ZEUS study (2014) (9)
Pathology of hepatic peroxisomes in chronic hepatitis B and immunosuppression. (1988) (9)
Plasmapheresis in the Therapy of Septic Disease (1996) (9)
Gene therapy: a possible future standard for HIV care. (2015) (9)
Immune monitoring of glucocorticoid therapy. (2002) (9)
Mannose-binding lectin deficiency is not associated with increased risk for polyomavirus nephropathy. (2012) (9)
Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - A New Standard in Therapy?. (2007) (9)
Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity (2017) (9)
Interim analysis of the largest prospective trial to date in adult CD20-positive post-transplant lymphoproliferative disorder (PTLD): Introducing risk-stratified sequential treatment (RSST). (2012) (8)
Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infection (2016) (8)
High prevalence of S. pyogenes Cas9-specific T cell sensitization within the adult human population – A balanced effector/regulatory T cell response (2018) (8)
Increased alloreactivity and adverse outcomes in obese kidney transplant recipients are limited to those with diabetes mellitus. (2017) (8)
Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo (2021) (8)
Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation (2022) (7)
A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation (2019) (7)
Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using an integration free vector. (2016) (7)
Monotherapy with the anti-CD20 antibody rituximab (ritux) in patients with post-transplant lympho-proliferative disease (PTLD). Results of a multicentre phase II study. (2002) (7)
Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in de Novo Renal Transplant Patients: 4 Years Follow-Up of the ZEUS Trial: 1671 (2012) (7)
Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective (2022) (7)
Synergism of CTLA4-IG and anti-CD4 monoclonal antibody treatment in a rat kidney transplant model. (1997) (7)
Fcγ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder (2014) (6)
Discordant expression of LFA-1, VLA-4alpha, VLA-beta 1, CD45RO and CD28 on T-cell subsets: evidence for multiple subsets of 'memory' T cells. (1994) (6)
Risk-Stratified Cardiovascular Screening Including Angiographic and Procedural Outcomes of Percutaneous Coronary Interventions in Renal Transplant Candidates (2014) (6)
CD3+/LFA-1 "bright" T cells represent memory-type effector cells, which, during immune activation in kidney graft recipients, are marked by increased cytokine mRNA levels. (1995) (6)
Late acute rejection in renal allograft recipients is mediated by inflammatory rather than by cytotoxic T-cell-dependent mechanisms. (1997) (6)
Fast, efficient and virus-free generation of TRAC-replaced CAR T cells (2021) (6)
Response to Rituximab Induction Is a Predictive Biomarker in Post-Transplant Lymphoproliferative Disorder (PTLD) and Allows Successful Treatment Stratification in an International Phase II Trial Including 152 Patients (2015) (6)
Molecular Analysis of Renal Allograft Biopsies—More Than a Nice Toy for Researchers? (2013) (6)
Simultaneous pancreas/kidney transplant recipients are predisposed to tissue‐invasive cytomegalovirus disease and concomitant infectious complications (2017) (6)
Effects of expanded allocation programmes and organ and recipient quality metrics on transplant‐related costs in kidney transplantation – an institutional analysis (2019) (6)
Vitamin A metabolism is changed in donors after living-kidney transplantation: an observational study (2011) (6)
IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: 2 YEARS FOLLOW-UP OF THE ZEUS TRIAL: 1757 (2010) (6)
Estimated Nephron Number of the Donor Kidney: Impact on Allograft Kidney Outcomes. (2017) (6)
Generating Multiple Kidney Progenitors and Cell Types from Human Pluripotent Stem Cells. (2019) (5)
Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product (2020) (5)
The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation Outcome (2019) (5)
Strong Expansion of Human Regulatory T Cells for Adoptive Cell Therapy Results in Epigenetic Changes Which May Impact Their Survival and Function (2021) (5)
Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine (1999) (5)
Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment (2020) (5)
Immunostimulation with Cytokines in Patients with ‘Immunoparalysis’ (2002) (5)
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial (2013) (5)
RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe—Why the European Union Should Invest More! (2021) (5)
Cytotoxic Effects of Rabbit Anti-Thymocyte Globulin preparations on Primary Human Thymic Epithelial Cells. (2019) (5)
Late-acute renal allograft rejection and symptomless cytomegalovirus infection (1994) (5)
Risk Stratification for Renal Transplantation after Cardiac or Lung Transplantation: Single-Center Experience and Review of the Literature (2007) (5)
To be, or not to be immunocompetent (2013) (5)
Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients (2021) (5)
High-Mobility Group Box-1 Protein Serum Levels Do Not Reflect Monocytic Function in Patients with Sepsis-Induced Immunosuppression (2010) (5)
Kidney transplantation at the Charité: long tradition, elderly patients and the duration of hospitalization. (2002) (5)
Cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: a cohort study (2018) (5)
[The significance of liver changes as the cause of death in kidney transplant patients (an analysis of 68 autopsy cases)]. (1987) (5)
Collaboration for success: the value of strategic col-laborations for precision medicine and biomarker discovery (2016) (4)
An Individual Patient's “Body” on Chips—How Organismoid Theory Can Translate Into Your Personal Precision Therapy Approach (2021) (4)
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised (2019) (4)
BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients (2019) (4)
The ONE Study: Evaluation of Regulatory Cell Therapy in Kidney Transplantation Using a Harmonized Trial Design (2020) (4)
Heme Oxygenase‐1 Polymorphisms and Renal Transplantation Outcomes: Balancing at the Detection Limit of Allelic Association Studies (2008) (4)
TREATMENT OF SOLID ORGAN TRANSPLANT RECIPIENTS WITH AUTOLOGOUS EPSTEIN BARR VIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES (CTL). Running title: T cell therapy for PTLD in Solid organ transplant recipients (2006) (4)
Postnatal development of hepatocytes following oxygen deficiency in utero. (1986) (4)
Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai virus technology. (2017) (4)
Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial (2011) (4)
Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study (2016) (4)
WITHDRAWN: Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai technology. (2016) (4)
Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study (2021) (3)
SEQUENTIAL TREATMENT WITH RITUXIMAB AND CHOP CHEMOTHERAPY IN B-CELL PTLD – WILL RISK STRATIFIED SEQUENTIAL TREATMENT BECOME THE NEW STANDARD IN THERAPY?: 292 (2008) (3)
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry (2021) (3)
Factors and outcomes in association with sepsis differ between simultaneous pancreas/kidney and single kidney transplant recipients (2018) (3)
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients (2022) (3)
[Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection]. (2003) (3)
A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation (2018) (3)
Association between the accumulation of hepatitis B virus core gene deletion mutants and progression of liver disease in long-term renal transplant patients. (1997) (3)
Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients (2020) (3)
The effect of induction therapy on established CMV specific T cell immunity in living donor kidney transplantation. (2018) (3)
Surgery for Renal Hyperparathyroidism in the Era of Cinacalcet: A Single-Center Experience (2020) (3)
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient and Allograft Survival in Long-term Follow-up After Kidney Transplantation (2017) (3)
Placental-expanded, mesenchymal cells improve muscle function following hip arthroplasty (2018) (3)
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study (2018) (3)
Invited letter in response to “Predicted indirectly recognizable HLA epitopes (PIRCHE): Only the tip of the iceberg?” (2018) (2)
Culture surface influence on T-cell phenotype and function. (2013) (2)
Serum levels of soluble interleukin-2 receptor, C-reactive protein, neopterin, myoglobin and light chains of cardiac myosin fail to correlate with the occurrence of rejection in long-term renal and heart transplant patients (1992) (2)
Cytomegalovirus infections in kidney transplant patients (2002) (2)
VALIDATION OF MONOCYTE HLA-DR EXPRESSION LESS THAN 30% AS A MARKER OF IMMUNE PARALYSIS IN CHILDREN WITH MULTIPLE ORGAN DYSFUNCTION (1999) (2)
Monitoring Temporary Immunodepression by Flow Cytometric Measurement of Monocytic HLA-DR Expression : A Multicenter Study (2005) (2)
T cell receptor repertoires within liver allografts are different to those in the peripheral blood. (2020) (2)
MODIFICATION OF IMMUNOSUPPRESSION CAN ENHANCE THE RECONSTITUTION OF BKV-SPECIFIC IMMUNITY PREVENTING GRAFT FAILURE DUE TO BKV-ASSOCIATED NEPHROPATHY IN RENAL TRANSPLANT PATIENTS: 1889 (2010) (2)
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective (2023) (2)
Preformed donor‐reactive T cells that persist after ABO desensitization predict severe T cell‐mediated rejection after living donor kidney transplantation – a retrospective study (2019) (2)
Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD (2021) (2)
Immune Monitoring and Strategies for Immune Modulation (2003) (2)
KIDNEY TRANSPLANTATION WITH CAMPATH 1H AND INFLIXIMAB INDUCTION FOLLOWED BY EITHER TACROLIMUS OR SIROLIMUS MONOTHERAPY: 12-MONTHS FOLLOW-UP: 2580 (2010) (2)
Treatment of Anti-HLA Donor-Specific Antibodies Results in Increased Infectious Complications and Impairs Survival after Liver Transplantation (2020) (2)
The perisinusoidal functional unit in amyloidosis. (1987) (2)
Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial: 1684 (2012) (2)
Sex-associated differences in cytomegalovirus prevention: Prophylactic strategy is associated with a strong kidney function impairment in female renal transplant patients (2019) (2)
PREDICTIVE VALUE OF THE COMBINATION OF TNF‐a LOW AND IL‐10 LOW PRODUCER GENOTYPES AND HIGH EBV VIRUS LOAD FOR THE DEVELOPMENT OF PTLD IN SOLID ORGAN TRANSPLANT PATIENTS.: Abstract# 265 Poster Board #‐Session: P112‐I (2000) (2)
RISK STRATIFIED SEQUENTIAL TREATMENT WITH RITUXIMAB AND CHOP CHEMOTHERAPY IN B-CELL PTLD - DEFINING A NEW STANDARD OF CARE: RESULTS FROM A PROSPECTIVE INTERNATIONAL MULTICENTER TRIAL: 1322 (2010) (2)
Early prediction of renal graft function: Analysis of a multi-centre, multi-level data set (2021) (2)
ANALYSIS OF CONVERSION FROM MYCOPHENOLATE MOFETIL TO ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS, MYFORTIC) IN RENAL TRANSPLANT PATIENT USING PATIENT-REPORTED OUTCOMES: 974 (2008) (2)
Outcome On Renal Function of an Everolimus Based Therapy After Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 5 Year Data of the APOLLO Trial.: Abstract# 2920 (2014) (2)
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population (2018) (2)
Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen.: Abstract# C1917 (2014) (1)
[Liver diseases in patients with kidney transplants--problems and research tasks]. (1987) (1)
ADOPTIVE IMMUNOTHERAPY: FUNCTIONAL CHARACTERISATION OF EPSTEIN-BARR-VIRUS (EBV) SPECIFIC T CELLS GENERATED BY SHORT TIME STIMULATION WITH EBV PEPTIDES: 2194 (2008) (1)
[Structure and function of the sinusoidal wall of the liver ("the perisinusoidal functional unit"). A review]. (1987) (1)
Immunomodulatory therapies: challenges of individualized therapy strategies. (2006) (1)
The use of polymerase chain reaction (PCR) in the detection and characterization of HBV variants (1996) (1)
[Cytomegalovirus infections in patients after organ transplantation. Epidemiology, diagnosis, therapy]. (2000) (1)
ATG VERSUS BASILIXIMAB INDUCTION THERAPY IN KIDNEY ALLOGRAFT RECIPIENTS RECEIVING A DUAL IMMUNOSUPPRESSIVE REGIMEN: SIX-YEAR RESULTS: 800 (2008) (1)
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivation. (2022) (1)
Reticulocytes and their immature fraction do not detect acute rejection after kidney transplantation. (2007) (1)
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation (2020) (1)
Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life (2017) (1)
Investigating the health-economic profiles of biomarker-driven immunosuppresion (BIO-DrIM) following solid organ transplantation (2016) (1)
MULTI-CENTER, OPEN-LABEL, PROSPECTIVE, RANDOMIZED, PARALLEL GROUP STUDY INVESTIGATING AN EVEROLIMUS-BASED CNI-FREE REGIMEN IN COMPARISON TO A CYCLOSPORINE-BASED STANDARD THERAPY IN DE NOVO RENAL TRANSPLANT PATIENTS (ZEUS STUDY): 1640 (2008) (1)
Efficacy and safety of sequential treatment with rituximab and CHOP chemotherapy in B-cell PTLD: Results of a prospective international phase II study (2007) (1)
[New developments in the immunodiagnosis of patients in intensive care]. (1999) (1)
Risk management after cardiopulmonary resuscitation--what is the real threat? (2008) (1)
ADENOVIRUS-MEDIATED GENE TRANSFER OF IL-4 PROLONGS RAT RENAL ALLOGRAFT SURVIVAL AND INHIBITS p21ras DEPENDENT ACTIVATION PATHWAY (1999) (1)
Intramuscular and intratendinous placenta‐derived mesenchymal stromal‐like cell treatment of a chronic quadriceps tendon rupture (2022) (1)
Strategy to achieve biomarker-driven immunosuppression after solid organ transplantation by an academic-industry partnership within the European BIO-DrIM consortium (2016) (1)
Measurement of Interferon-Gamma Induced Protein 10 in Serum: A Risk Assessment Approach for BKV-Associated Nephropathy: 985 (2012) (1)
Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life After Kidney Transplantation (2018) (1)
Post Hoc Analysis of ZEUS and HERAKLES, Two Prospective, Open-Label, Multicenter, Randomized Trials: Onset and Progression of Diabetes in Kidney Transplant Recipients On Cyclosporine Standard or Converted to CNI-Free or CNI-Low Everolimus Regimen.: Abstract# 2921 (2014) (1)
Electron microscopy of liver in patients with chronic haemodialysis. (1991) (1)
Kaletra® Single Agent HAART after Intolerance of NRTI- and NNRTI-Containing Regimens Following Kidney Transplantation (2007) (1)
Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies (2021) (1)
On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes (2022) (1)
Outcome of Cardiovascular Screening and Percutaneous Coronary Interventions in Renal Transplant Candidates: A Single-Center Observational Study in Germany: 2090 (2012) (1)
Generation of 20 human induced pluripotent stem cell lines from patients with focal segmental glomerulosclerosis (FSGS). (2021) (1)
[Ultrasound diagnosis of the transplanted kidney]. (1996) (0)
Human natural regulatory T cells subsets : Functional characterization and T cell receptor repertoire analysis (2014) (0)
[Ultrastructure of intralobular lymphocyte migration in the liver of hemodialysis patients]. (1989) (0)
Outcome on renal function, efficacy and safety in living-donor kidney transplant recipients after conversion from cni to everolimus-based regimen: 5 year data post hoc analysis from the zeus study (2015) (0)
A method for antigen-specific stimulation of T lymphocytes (2000) (0)
INDUCTION THERAPY WITH POLYCLONAL ATG IMPROVES LONG-TERM BUT NOT SHORT-TERM OUTCOME OF CADAVER RENAL ALLOGRAFTS (1998) (0)
SP719IMPAIRED CELLULAR IMMUNITY PREDISPOSES KIDNEY TRANSPLANT RECIPIENTS TO THE DEVELOPMENT OF CANCER (2017) (0)
Renal transplantation - clinical studies - 2 (2009) (0)
CYTOKINE GENE TRANSFER IN HEART ALLOGRAFTS DOES NOT INDUCE TOLERANCE IN HIGH RESPONDER STRAIN COMBINATION (1999) (0)
Intensive blood pressure control is associated with improved patient and graft survival after renal transplantation (2019) (0)
Corrigendum to "Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using an integration free vector" [Stem Cell Res. 16/2 (2016) 314-317]. (2016) (0)
Kidney Transplant Survival In Patients With Preformed Donor-Specific HLA Antibodies In Solid-Phase Assays (2017) (0)
Highly Sensitized Patients: Targeting Alloreactive T-Cells in Renal Re-Transplantation.: Abstract# 1365 (2014) (0)
Kidney transplant monitoring by urinary flow cytometry: Biomarker combination of T cells, renal tubular epithelial cells, and podocalyxin-positive cells detects rejection (2020) (0)
Differences in Outcome and Compliance Between Renal Transplant Patients With Migration Background and Native-Born German Patients.: Abstract# D2503 (2014) (0)
Out-of-the-black-box: Standardisation of the EliSpot Method for immunomonitoring in personalized Immunosupression after solid organ tranplantation (2020) (0)
IL-6 AND TNF ALPHA PLASMA LEVELS BUT NOT IL-10 PLASMA LEVELS CORRELATE WITH RESPONSE TO TREATMENT IN PATIENTS WITH PTLD: A LONGITUDINAL ANALYSIS FORM THE GERMAN PTLD REGISTRY D 2006–2012: 1567 (2010) (0)
Cytokine mRNA expression analysis in renal transplantation - a new protocol based on a non-invasive screening method in urine cells for acute rejection (2002) (0)
ABO Desensitization Induces CD4+ Lymphocytopenia After Renal Transplantation.: Abstract# A171 (2014) (0)
Ratten-Cytomegalievirusinfektion interferiert mit anti-CD4-MoAb (RIB 5/2)-induzierter Toleranz und führt zu einer chronischen Allotransplantatschädigung (2005) (0)
SP784DIFFERENT RISK FACTOR PROFILES DISTINGUISH EARLY-ONSET FROM LATE-ONSET BKV-REPLICATION (2015) (0)
Clindamycin-Primaquine Is Safe in Treating Pneumocystis Pneumonia in Renal Transplant Patiens but Appears to Be Less Effective than Trimethoprim/Sulfamethoxazole: 2097 (2012) (0)
SO024DONOR RECIPIENT MATCHING BASED ON INDIRECTLY RECOGNIZABLE HLA EPITOPES INDEPENDENTLY PREDICTS OUTCOME AFTER KIDNEY TRANSPLANTATION (2017) (0)
MRNA INDUCTION OF CYTOTOXIC MOLECULES IN URINE AFTER KIDNEY TRANSPLANTATION: A NON-INVASIVE APPROACH (2004) (0)
[The syndrome of retrograde venous arterialization following arteriovenous vascular anastomoses for hemodialysis]. (1988) (0)
and CD45 isoforms (1999) (0)
PUK10 - ANALYZING HEALTH-ECONOMIC EFFECTS OF A RENAL PRE-TRANSPLANT PATIENT-STRATIFICATION TOOL AT AN EARLY STAGE OF PRODUCT DEVELOPMENT (2018) (0)
ELISA; and tissue Granzyme-B mRNA transcript, in renal biopsy specimen by Taqman real time PCR and GzmB protein expression by Immunohistochemistry, in both groups (2017) (0)
[The vascular pole of hepatocytes: structure, function and pathology]. (1986) (0)
In vitro and In vivo evidence that the switch from calcineurin to mTOR-inhibitors may be a strategy for immunosuppression in Epstein-Barr-Virus-associated post-transplant lymphoproliferative disorder. (2022) (0)
MP779LEFT-SIDED DONOR NEPHRECTOMY PREDISPOSES LIVING KIDNEY DONORS TO LATENT ADRENAL INSUFFICIENCY WITH SYMPTOMS OF FATIGUE AND INFERIOR QUALITY OF LIFE (2017) (0)
Novel GMP-Feasible Approach to Generate Virus-Specific Long-Lived Memory T Cells for Adoptive Immunotherapy on Immunosuppressed Solid Organ Transplant and Dialysis Recipients: 2450 (2012) (0)
The role of CD4+ T cells in BKV-specific T cell immunity (2014) (0)
[The sinusoid wall of the liver in viral infections]. (1986) (0)
MP692EVALUATION OF SPECIFIC T CELL RESPONSES PRIOR KIDNEY TRANSPLANTATION: USEFUL TOOL FOR REJECTION PREDICTION? (2016) (0)
SO014THE PRESENCE OF CMV-SPECIFIC T-CELLS IN CMV-SERONEGATIVE KIDNEY TRANSPLANT RECIPIENTS PREDICTS OUTCOME AFTER KIDNEY TRANSPLANTATION (2016) (0)
MONITORING OF BKV LOAD IN URINE ALLOWS IDENTIFICATION OF PATIENTS WITH THE HIGH RISK FOR BKV-ASSOCIATED NEPHROPATHY SEVERAL WEEKS PRIOR TO DEVELOPMENT OF VIREMIA: ANALYSIS OF 4128 URINE AND SERUM SAMPLES: 230 (2008) (0)
[Systemic candidiasis in patients after kidney and heart transplantation]. (1990) (0)
Low-Dose Interleukin-2 Therapy: Effects in Chronic Renal Allograft Dysfunction.: Abstract# A268 (2014) (0)
Corrigendum to "VEGF - Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC" [Biomaterials 216 (2019) 119283 1-10]. (2019) (0)
Criteria and Relevant Prognostic Factors in Donor Selection, an Analysis of 266 Consecutive Donor Nephrectomies. (2018) (0)
Underlying Renal Disease With Iincreased Infection Risk is Associated With Inferior Patient Survival (2018) (0)
Sensitization to MHC Antigen Is Characterized By Heightened Early Proinfl ammatory Cytokine Release Rather Than Lymphocyte Proliferation: Implications for Sensitization After Allograft Rejection (2017) (0)
RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS ONE YEAR AFTER CONVERSION: 1742 (2010) (0)
Subject Index Vol. 42, 1999 (2000) (0)
Concerted Action of Both, Cytolytic and Helper T-Cells, Is Necessary for BKV Clearance.: Abstract# B1004 (2014) (0)
T cell homeostasis and memory (PP-059) (2010) (0)
DIMINISHED LEVELS OF DEHYDROEPIANDROSTERONE-SULFATE IN LONG-TERM RENAL TRANSPLANT PATIENTS ARE ASSOCIATED WITH POORER GRAFT FUNCTION (1998) (0)
Selective in vivo deletion of alloactivated Th1 cells by OKT 3 mAb in acute rejection (1997) (0)
SP715UNDERLYING RENAL DISEASE WITH INCREASED INFECTION RISK IS ASSOCIATED WITH INFERIOR PATIENT SURVIVAL (2018) (0)
Tuesday, May 13, 2008: Free Communications (2008) (0)
Chapter 11 IMMUNOSTIMULATION IN SEPSIS (2001) (0)
Donor or recipient origin of posttransplantation lymphoproliferative disorders: the traces of the Epstein-Barr virus. (2001) (0)
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN PEDIATRIC HEART TRANSPLANTATION. INTERPLAY BETWEEN PRIMARY EPSTEIN-BARR VIRUS INFECTION AND IMMUNOSUPPRESSION: 570 (2008) (0)
Immunoadsorption of lipopolysaccharides, IL-6 and complement-activation product 5a in severe sepsis and septic shock (2006) (0)
Immunity to virus infection (excluding retroviruses) 2 (WS-025b) Chairpersons: Tsukasa Seya, Iain Campbell (2010) (0)
SP720STRATIFICATION OF KIDNEY TRANSPLANTAT RECIPIENTS INTO THOSE WITH LOW AND HIGH ALLOREACTIVE T-CELLS MAY ALLOW SAFE CONVERSION TO mTOR-INHIBITOR-BASED IMMUNOSUPPRESSION (2017) (0)
Methylprednisolone Therapy of Deceased Donors Could Improve Clinical Outcome after Kidney Transplantation: 873 (2012) (0)
Renal transplantation - basic research (2009) (0)
[Treatment of autoimmune diseases and graft rejection with anti-CD4 antibodies]. (1992) (0)
MRNA induction of the NK cell receptor NKG2D during acute rejection following kidney transplanation (2005) (0)
[Autopsy analysis of the cause of death in patients with kidney transplants]. (1988) (0)
IP10 MRNA AND PROTEIN EXPRESSION AS A PREDICTIVE MARKER FOR ACUTE REJECTION IN URINE OF RENAL TRANSPLANT RECIPIENTS (2004) (0)
Inhalt – Contents, Vol. 11, Supplement 2, 1995 (1995) (0)
PHARMACODYNAMIC MONITORING OF DE NOVO RENAL TRANSPLANT RECIPIENTS UNDERGOING CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS IN COMBINATION WITH MYCOPHENOLATE: 1200 (2008) (0)
Differential immune response against two BK virus antigens explains control of BK viremia post-kidney transplant (2016) (0)
INFLUENCE OF PREFORMED DONORSPECIFIC HLA-ANTIBODIES ON KIDNEY TRANSPLANTATION - FIRST RESULTS OF A MULTICENTER RETROSPECTIVE STUDY (2016) (0)
Abstract Session IV - Transplantation (2003) (0)
INDUCTION OF HEMOXYGENASE‐1 (HO‐1) IN GRAFTS FROM ‘ELDERLY’ DONORS WITH PROLONGED ISCHEMIA IMPROVES LONG‐TERM FUNCTION.: Abstract# 355 Poster Board #‐Session: P202‐I (2000) (0)
Adoptive cellular immunotherapy for viral diseases post-transplant (2017) (0)
New technology in immunology (PP-063) (2010) (0)
CTL-based immunotherapy (PP-109) (2010) (0)
INFLUENCE OF MEDICAL IMMUNOSUPPRESSION ON CMV-SPECIFIC T-CELL THERAPY: CONCLUSIONS FROM IN VITRO- AND CLINICAL OBSERVATIONS: 554 (2008) (0)
Effects of Treatment of Asymptomatic Hyperuricemia on Graft Survival and Mortality in Kidney Transplant Recipients. (2016) (0)
Immunological kidney diseases (WS-098) Chairpersons: Yasuhiko Tomino, Jan Novak (2010) (0)
Explorative analysis of zeus after 5 years: histological assessment from biopsy analyses (2015) (0)
Tolerance induction in rat transplantation models by anti-CD4 mAb is associated with intragraft upregulation of IL-4 - but intragraft overexpression of IL-4 is not sufficient for tolerance induction (1998) (0)
Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients (2013) (0)
GARP as a Tool to Identify Antigen-Specific Human Tregs.: Abstract# B1144 (2014) (0)
Measuring T-Cell Reactivity to Cytomegalovirus: State of the Art (2003) (0)
Decreased Allograft Survival After BK Viremia: Impact of Alloreactive T-Cells On Graft Injury.: Abstract# B1020 (2014) (0)
A 2nd generation antiviral T cell product for sustained immunological regeneration (2017) (0)
ACCURATE PREDICTION OF KIDNEY ALLOGRAFT OUTCOME BASED ON CREATININE COURSE IN THE FIRST YEAR POST-TRANSPLANT (2004) (0)
FO050TWO DECADES OF EUROTRANSPLANT SENIOR PROGRAM (ESP): TIME ON DIALYSIS INDEPENDENTLY IMPACTS PATIENT SURVIVAL, ALLOGRAFT SURVIVAL AND QUALITY OF LIFE AFTER KIDNEY TRANSPLANTATION (2018) (0)
[Transplantation immunology]. (1999) (0)
Reinke Regeneration in Humans T Cells Negatively Affect Bone + Terminally Differentiated CD 8 (2013) (0)
Agents for the treatment of the disease Crohn's disease (1998) (0)
Presence of Bcr-Abl Positive Cells in Peripheral Blood Leukocytes of Immunosuppressed Solid Organ Transplant (SOT) Recipients (2008) (0)
SO025DONOR RECIPIENT MATCHING BASED ON HLA EPITOPES IMPROVES OUTCOME IN KIDNEY TRANSPLANT RECIPIENTS (2017) (0)
SP746NEPHRECTOMY OF THE FAILED FIRST KIDNEY ALLOGRAFT PREDISPOSES KIDNEY TRANSPLANT RECIPIENTS TO PRESENSITIZATION WITH ALLOREACTIVE T-CELLS AND INFERIOR ALLOGRAFT SURVIVAL AFTER RETRANSPLANTATION (2017) (0)
Investigating The Health-Economic Impact Of Biomarker-Driven Immunosuppression (Biodrim) Following Renal Transplantation. (2015) (0)
Pentoxifylline (PTX) promotes replication of human cytomegalovirus (HCMV) (1997) (0)
Explorative post hoc analysis of zeus after 5 years: histological assessments from biopsies (2015) (0)
Dialysis therapy is associated with peripheral marginal zone B-cell augmentation. (2020) (0)
Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells (2022) (0)
FO066Predicted Indirectly ReCognizable HLA Epitopes Are Associated with T-Cell Mediated Rejection Among Kidney Transplant Recipients with Preformed and De-novo Donor-Reactive T-Cells (2019) (0)
SP806BIRTH WEIGHT AS A MARKER OF NEPHRON MASS: PREDICTING DONOR AND RECIPIENT OUTCOMES (2015) (0)
Human Bone Marrow as a Source of Multifunctional CMV-Specific CD4+ T Cells for Adoptive Cell Therapy. (2007) (0)
IMMUNOADSORPTION OF ENDOTOXIN, IL-6 AND C5A IN SEVERE SEPSIS AND SEPTIC SHOCK.: 202-T (2005) (0)
SYMPTOMATIC LYMPHOCELES AFTER KIDNEY TRANSPLANTATION – MULTIVARIATE ANALYSIS OF RISK FACTORS AND OUTCOME AFTER LAPAROSCOPIC FENESTRATION: 1571 (2008) (0)
Parallel generation of easily selectable multiple nephronal cell types from human pluripotent stem cells (2018) (0)
ROLE OF REGULATORY T CELLS IN ADOPTIVE CMV-SPECIFIC T-CELL THERAPY: 2188 (2008) (0)
Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome. (2022) (0)
KIR/HLA INCOMPATIBILITY IS ASSOCIATED WITH ACUTE REJECTION IN KIDNEY TRANSPLANTATION (2006) (0)
Massive elevation of systemic procalcitonin levels in kidney transplant patients treated with anti-CD3 monoclonal antibody (OKT3) (1999) (0)
EBV-RELATED MONOCLONAL GAMMOPATHY (MGUS) IN LONG-TERM RENAL ALLOGRAFT RECIPIENTS IS ASSOCIATED WITH ACTIVATION OF CD8+ T CELLS WHICH MAY PREVENT DEVELOPMENT OF B-CELL LYMPHOMA (1998) (0)
Urinary Renal Biomarkers for Early Graft Surveillance after Living and Deceased Donor Kidney Transplantation: 1123 (2012) (0)
T Cells + Role of CD4 IL-2 Receptor Signaling Pathway: The Key Memory T Cells by Partial Targeting of the Virus-Specific Multifunctional Central Preferential Expansion of Human (2012) (0)
FP841DIABETIC KIDNEY TRANSPLANT RECIPIENTS: IMPAIRED INFECTION CONTROL AND ALLOREACTIVITY (2015) (0)
Method and kit for testing different, selected materials and / or surface structures for the culture of cells (2009) (0)
Reply to: ‘BKV replication and cellular immune response in renal transplant recipients’ (2006) (0)
Poster Sessions (2018) (0)
SP767PROVISION OF HIGHLY SPECIALIZED AFTERCARE BY THE TRANSPLANT CENTER STRONGLY IMPROVES PATIENT AND ALLOGRAFT SURVIVAL IN LONG-TERM FOLLOW-UP AFTER KIDNEY TRANSPLANTATION (2017) (0)
Immunostimulation in Sepsis (2001) (0)
PREVENTION OF ISCHEMIA/REPERFUSION INJURY AND IMPROVED LONG‐TERM GRAFT OUTCOME FOLLOWING HEMEOXYGENASE (HO‐1) INDUCTION IN RAT RENAL ALLOGRAFT.: Abstract# 66 (2000) (0)
Regulatory T cells (PP-045) (2010) (0)
Establishment of Alloantigen Cell Bank Allowing High Resolution Analysis of T Cell Alloimmunity.: Abstract# B756 (2014) (0)
Cytomegalovirus-Specific Regulatory T Cells and their Role in Repetitive CMV Infections in Solid Organ Transplanted Patients: 1450 (2012) (0)
Immune Monitoring in BK Viurs Nephropathy: How to Identify Patients at the Highest Risk.: Abstract# B1005 (2014) (0)
Post hoc subgroup analysis of zeus: outcome on renal function, efficacy and safety in living-donor kidney transplant recipients after conversion from a calcineurin inhibitor to an everolimus based regimen: 5 year follow-up data (2015) (0)
Pathophysiology of Immunodepression in ICU Patients (2002) (0)
Incompatibility between KIR2DL1 and its HLA-C ligands is associated with acute rejection in kidney transplantation (2005) (0)
1898. Clinical Characteristics of Patients With Solid-Organ Transplantation (SOT) and Norovirus (NV) Infections (2018) (0)
NEW PROTOCOL OF BKV-SPECIFIC T CELL ANALYSIS ALLOWS FOR IMPROVED ASSESSMENT OF PHENOTYPIC AND FUNCTIONAL CHARACTERISTICS OF BKV-SPECIFIC IMMUNITY: 1776 (2010) (0)
Peripheral T cell activation in long term renal transplant recipients: Upregulation of adhesion molecules corresponds to cytokine gene transcription (1997) (0)
Transplantation - clinical II (2012) (0)
[De novo diabetic glomerulosclerosis in kidney transplants]. (1989) (0)
Treatment of dilated cardiomyopathy by distance from Autoantibody (1996) (0)
Monitoring of T cell HCMV reactivity in transplant recipients (1999) (0)
Cell Line Generation of integration free induced pluripotent stem cells from fi brodysplasia ossi fi cans progressiva ( FOP ) patients from urine samples (2015) (0)
SP681ADVERSE OUTCOMES IN OBESE KIDNEY TRANSPLANT RECIPIENTS ARE LIMITED TO THOSE WITH DIABETES (2016) (0)
FP871TREATMENT OF ASYMPTOMATIC HYPERURICEMIA AFTER RENAL TRANSPLANTATION (2015) (0)
ABSTRACTS Open Access Kitasato Symposium 2011 : Translational prospects for cytokines in 2011 Potsdam , Germany . 22-23 September 2011 (2011) (0)
MO023MALIGNANCIES CONTRIBUTE TO PRESENSITIZATION WITH ALLOREACTIVE T-CELLS PRIOR TO TRANSPLANTATION (2016) (0)
Relevance and targeting of memory T cells in transplantation (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Petra Reinke?

Petra Reinke is affiliated with the following schools:

University of Duisburg-Essen
Humboldt University of Berlin
University of California, Berkeley
Stanford University